http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002300897-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2baf849d216e689ecc40ccc931a7a7bc http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6c8d4dc7bd1a30d8fda907fceaeb4e69 |
classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-72 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P41-00 |
filingDate | 2002-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_531c34b4e63554454641045e8fee1da8 |
publicationDate | 2002-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2002300897-A |
titleOfInvention | Production of (3R, 5S)-(E) -7- [2-cyclopropyl-4- (4-fluorophenyl) -quinolin-3-yl] -3,5-dihydroxyhept-6-enoic acid esters Method |
abstract | (57) Abstract: (3R, 5S)-(E) -7- [2-cyclopropyl-4- (4-fluorophenyl) -quinoline- 3-yl] -3,5-dihydroxyhept-6-enoic acid esters. SOLUTION: The following formula (I): (Wherein, R represents a hydrogen atom, an alkyl group or an aryl group), a compound represented by the following formula (II): Wherein R is as defined above, and a compound represented by the following formula (III): Wherein R is as defined above, a cell selected from the group consisting of compounds represented by the following formulas and / or treated with microorganisms having the ability to stereoselectively reduce keto groups: The following formula (I) V) (Wherein, R has the same meaning as described above). |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10815201-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10676441-B2 |
priorityDate | 2001-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 160.